Global Fund invites Myanmar to apply for additional funding

NewsGuard 100/100 Score

"Health workers in Myanmar are confident that efforts to narrow the country's huge gap between access to, and need for, life-saving medicines to treat HIV/AIDS are back on track after the Global Fund to Fight AIDS, Tuberculosis and Malaria invited the country to apply for additional funding," IRIN reports. "The agency's coordinator for Myanmar, Eamonn Murphy, said new funds will allow the country to close a 'treatment gap' where only one-third of the 120,000 people nationwide who need [antiretrovirals (ARVs)] receive them," the news service notes. "A spokesman for the Global Fund said it 'had encouraged an application by the country for more money' following an August visit to Myanmar by its general director," IRIN writes. "Health officials drafted a 'concept note' outlining how additional funding might be used, which will be reviewed by the Global Fund's board, Murphy said," according to the news service, which notes, "It offers two scenarios: the first ensures 85 percent of those who need ARVs receive them by 2015; while with the second, 76 percent of people would be covered, he said." The news service adds, "Based on feedback from the board, the government will choose a strategy for the proposal to be submitted early next year" (10/12).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Single dose of malaria monoclonal antibody 77% effective in children, trial in Mali shows